| For: | Tonini V, Zanni M. Pancreatic cancer in 2025: Have we found a solution? World J Gastroenterol 2025; 31(43): 111433 [PMID: 41358172 DOI: 10.3748/wjg.v31.i43.111433] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v31/i43/111433.htm |
| Number | Citing Articles |
| 1 |
Stanisław Surma, Dawid Szkudłapski, Kazimierz Ciechanowski. Hormones in Neuroscience. 2026; doi: 10.1016/B978-0-443-30263-3.00039-7
|
| 2 |
Laura Radoš, Sara Matulić Čubranić, Marin Golčić, Iva Skočilić, Ivana Mikolašević, Andrej Belančić. Contemporary Landscape of Active Clinical Trials in Pancreatic Ductal Adenocarcinoma: A ClinicalTrials.gov—Based Narrative Review with a Scoping Approach. Pharmaceuticals 2026; 19(9) doi: 10.3390/ph19091371
|
| 3 |
Seher Hekimsoy, Aliye Soylu, Mehmet Bayram, Hafize Uzun, Omur Tabak. Evaluation of Pancreatic Lesions: Comparative Analysis of Endoscopic Ultrasonography, Computed Tomography, and Magnetic Resonance Imaging. Medicina 2026; 62(5) doi: 10.3390/medicina62050982
|
| 4 |
Yanzhao Mao, Yuqi Zhang, Yupeng Zhang, Dongwei Lin, Yuelin Song, Xiaojiang Niu, Peihao Xv, Yuliang Wang, Zhigang Wei. Unraveling the roles of DKK1 and S100P in pancreatic ductal adenocarcinoma: Insights from machine learning, single-cell/spatial transcriptomics, and functional validation. Translational Oncology 2026; 72 doi: 10.1016/j.tranon.2026.102949
|
| 5 |
Qamar Abuhassan, Hamzeh J. Al-Ameer, Shahad Mohammed Dhiaa Younis, Jasur Rizaev, Makhfirat Kibriyeva, Rasim M. Salih, Mohamed Adil Jaber. Emerging nanoparticle approaches for early detection and therapeutic targeting of pancreatic cancer. Clinica Chimica Acta 2026; 590 doi: 10.1016/j.cca.2026.121102
|
| 6 |
Jun Yu, Yuan Pan, Yi Chen, Zhihui Shu, Lin Ma, Bin Wu, Jingdong Li, Jianshui Li, Chuan Lan. High SOX17 expression is correlated with favorable prognosis and CD8(+) TILs expression in patients with pancreatic cancer after curative resection. Translational Oncology 2026; 70 doi: 10.1016/j.tranon.2026.102859
|
| 7 |
Laura Gehrcken, Jasper Ott, Astrid Van den Eynde, Ho Wa Lau, Dana Liu, Christophe Hermans, Tias Verhezen, Stefanie Peeters, Carole Faghel, Philippe Joye, Gils Roex, Diana Campillo-Davo, Eva Lion, Filipe Elvas, Senada Koljenovic, Jorrit De Waele, Vera Hartman, Geert Roeyen, Hans Prenen, Filip Lardon, Christophe Deben, Evelien Smits, Jonas Van Audenaerde. IL-15 boosts mesothelin- and CD70-CAR NK cell potency in PDAC without added benefit from dual targeting. Molecular Therapy Oncology 2026; 34(3) doi: 10.1016/j.omton.2026.201316
|
| 8 |
Di Meng, Cheng Zhang. RAS signaling and remodeling of the immune microenvironment in pancreatic ductal adenocarcinoma: implications of emerging RAS-targeted therapy. Frontiers in Cell and Developmental Biology 2026; 14 doi: 10.3389/fcell.2026.1948028
|
| 9 |
İlkay Çıtakkul, Yasemin Bakkal Temi, Zehra Aytin, Ece Baydar, Umut Kefeli, Devrim Çabuk, Kazım Uygun. EASIX Score as an Independent Prognostic Marker in De Novo Metastatic Pancreatic Cancer. Medicina 2026; 62(3) doi: 10.3390/medicina62030562
|
| 10 |
Wenjing Ding, Yanchun Fang, Hanmeng Xu, Xinyu Zhang, Chao Li, Yanping Wang, Daoxiang Zhang. VDR Activation Suppresses Pancreatic Cancer Metastasis Through Inhibition of the ERK Signaling Pathway. Cancers 2026; 18(14) doi: 10.3390/cancers18142296
|
| 11 |
Nur Syahirah Haidah Zahid, Aziemah Azizi, Aklimah Mustapa, Syahirah Shahlehi, Masayoshi Arai, Siti Nur Idayu Matusin. Comparative In Vitro Cytotoxicity of Piper betle Leaf Extracts in KRAS G12D-Mutant Pancreatic Cancer Cell Lines. Current Issues in Molecular Biology 2026; 48(9) doi: 10.3390/cimb48090876
|